Artron Laboratories, Inc.
⚠️ High Risk
FEI: 3005445066 • Burnaby, British Columbia • CANADA
FEI Number
3005445066
Location
Burnaby, British Columbia
Country
CANADAAddress
3938 North Fraser Way, , Burnaby, British Columbia, Canada
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
NO PMA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
INCONSPICU
Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 11/7/2024 | 83QYTOVER-THE-COUNTER COVID-19 ANTIGEN TEST | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 11/9/2023 | 83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 10/19/2022 | 83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 4/8/2022 | 83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES | Division of Southeast Imports (DSEI) | |
| 3/8/2022 | 83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 2/24/2022 | 83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES | 237NO PMA | Division of Northern Border Imports (DNBI) |
| 2/18/2022 | 83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 1/27/2022 | 83QMNCOVID-19 MULTI-ANALYTE ANTIGEN DEVICE | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 12/9/2020 | 83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 11/4/2020 | 83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. | Division of Southeast Imports (DSEI) | |
| 10/5/2020 | 83QKOREAGENT, CORONAVIRUS SEROLOGICAL | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 9/14/2020 | 83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 9/11/2020 | 83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID | Division of Southeast Imports (DSEI) | |
| 7/25/2020 | 83QKOREAGENT, CORONAVIRUS SEROLOGICAL | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 6/29/2020 | 83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 6/25/2020 | 83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 6/24/2020 | 83QKOREAGENT, CORONAVIRUS SEROLOGICAL | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 6/18/2020 | 83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 5/6/2020 | 83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. | Division of Southeast Imports (DSEI) | |
| 4/23/2020 | 83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 4/21/2020 | 83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID | Division of Southeast Imports (DSEI) | |
| 9/21/2018 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | Division of Southeast Imports (DSEI) | |
| 5/10/2018 | 91MVOKIT, TEST, MULTIPLE DRUGS OF ABUSE, OVER THE COUNTER | Division of Southeast Imports (DSEI) | |
| 5/10/2018 | 88NJTIMMUNOHISTOCHEMISTRY REAGENTS AND KITS | Division of Southeast Imports (DSEI) | |
| 5/10/2018 | 88NJTIMMUNOHISTOCHEMISTRY REAGENTS AND KITS | Division of Southeast Imports (DSEI) | |
| 5/10/2018 | 88NJTIMMUNOHISTOCHEMISTRY REAGENTS AND KITS | Division of Southeast Imports (DSEI) | |
| 4/21/2016 | 82MZFTEST, HIV DETECTION | Cincinnati District Office (CIN-DO) | |
| 5/8/2015 | 82DDGTRANSFERRIN, ANTIGEN, ANTISERUM, CONTROL | New Orleans District Office (NOL-DO) | |
| 5/8/2015 | 75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN | New Orleans District Office (NOL-DO) | |
| 5/8/2015 | 75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN | New Orleans District Office (NOL-DO) | |
| 4/21/2015 | 81MVUREAGENTS, SPECIFIC, ANALYTE | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 4/21/2015 | 81MVUREAGENTS, SPECIFIC, ANALYTE | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 7/5/2013 | 82NTWSYSTEM, BLOOD COLLECTION, RNA STABILIZATION, RNA PURIFICATION, RT-PCR MOLECULAR DIAGNOSTIC TEST | 341REGISTERED | Florida District Office (FLA-DO) |
| 4/13/2012 | 91LDJENZYME IMMUNOASSAY, CANNABINOIDS | San Francisco District Office (SAN-DO) | |
| 4/13/2012 | 91DJPRADIOIMMUNOASSAY, AMPHETAMINE | San Francisco District Office (SAN-DO) | |
| 4/13/2012 | 91DLTHEMAGGLUTINATION, OPIATES | San Francisco District Office (SAN-DO) | |
| 9/30/2010 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | 118NOT LISTED | Seattle District Office (SEA-DO) |
| 12/18/2007 | 82MZFTEST, HIV DETECTION | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Artron Laboratories, Inc.'s FDA import refusal history?
Artron Laboratories, Inc. (FEI: 3005445066) has 38 FDA import refusal record(s) in our database, spanning from 12/18/2007 to 11/7/2024.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Artron Laboratories, Inc.'s FEI number is 3005445066.
What types of violations has Artron Laboratories, Inc. received?
Artron Laboratories, Inc. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Artron Laboratories, Inc. come from?
All FDA import refusal data for Artron Laboratories, Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.